• Home
  • Congress & Events
  • ECP 2023
  • Analytical and Clinical Performance of the VENTANA CLDN18 (43-14A) RxDx Assay in Gastric and Gastroesophageal Junction Adenocarcinoma Tissue Samples for Patient Identification in Two Phase 3 Trials of Zolbetuximab

ECP 2023

Sep 09 - Sep 13, 2023 | Dublin, Ireland / Virtual (Hybrid)

Share this page

Close Tooltip
Copy Link Tooltip

Copy page URL

Analytical and Clinical Performance of the VENTANA CLDN18 (43-14A) RxDx Assay in Gastric and Gastroesophageal Junction Adenocarcinoma Tissue Samples for Patient Identification in Two Phase 3 Trials of Zolbetuximab

Authors Stratton S, Pang L, Pugh J, Kouzova M, Baldwin D, McDonald J, Buckmeier J, Moran D, Guerruero A

Published date09 September, 2023

Study evaluating the performance of the investigational VENTANA CLDN18 (43-14A) RxDx Assay for IHC detection of CLDN18.2 to help identify patients with LA unresectable or mG/GEJ adenocarcinoma who could possibly benefit from zolbetuximab therapy in the SPOTLIGHT and GLOW trials.

Download Current View

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

Not a healthcare professional? Browse:

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

You are Leaving the Global Medically Site

By following this link, you are being redirected to another Roche page.